Drug name - Macrilen

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6861409 NOVO Growth hormone secretagogues
Aug, 2022

(a month ago)

CN1736985A NOVO Growth Hormone Secretagogues
Sep, 2007

(15 years ago)

CN1232507C NOVO Growth Hormone Secretagogues
Jun, 2021

(1 year, 3 months ago)

CN1431998A NOVO Growth Hormone Secretagogues
Jun, 2021

(1 year, 3 months ago)

IN224552B NOVO Growth Hormone Secretagogues
Jun, 2021

(1 year, 3 months ago)

IN200201550P3 NOVO Growth Hormone Secretagogues
Jun, 2021

(1 year, 3 months ago)

EP1524272B1 NOVO Growth Hormone Secretagogues
Jun, 2021

(1 year, 3 months ago)

EP1524272A1 NOVO Growth Hormone Secretagogues
Jun, 2021

(1 year, 3 months ago)

EP1344773B1 NOVO Growth Hormone Secretagogues
Jun, 2021

(1 year, 3 months ago)

EP1344773A1 NOVO Growth Hormone Secretagogues
Jun, 2021

(1 year, 3 months ago)

EP1289951B1 NOVO Growth Hormone Secretagogues
Jun, 2021

(1 year, 3 months ago)

EP1289951A1 NOVO Growth Hormone Secretagogues
Jun, 2021

(1 year, 3 months ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8192719 NOVO Methods and kits to diagnose growth hormone deficiency by oral administration of EP 1572 or EP 1573 compounds Oct, 2027

(5 years from now)

Drugs and Companies using MACIMORELIN ACETATE ingredient

Treatment: A method for the diagnosis of adult growth hormone deficiency by measuring the level of growth hormone after oral administration of macimorelin

Dosage: FOR SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 60MG BASE/POUCH FOR SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.